永赢医药创新智选混合发起A(015915)财务指标
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 本期已实现收益 |
6,860,584.83 |
23,727,500.46 |
10,031,531.90 |
-5,120,778.86 |
| 本期利润 |
-51,846,247.46 |
-61,542,749.72 |
54,143,173.67 |
-6,459,768.63 |
| 加权平均基金份额本期利润 |
-0.07 |
-0.19 |
0.57 |
-0.20 |
| 本期加权平均净值利润率(%) |
-4.55 |
-10.99 |
42.66 |
-22.52 |
| 本期基金份额净值增长率(%) |
-2.75 |
74.70 |
69.39 |
-12.14 |
| 期末可供分配利润 |
-98,513,133.25 |
-131,232,306.38 |
-49,523,132.06 |
-8,557,264.83 |
| 期末可供分配基金份额利润 |
-0.17 |
-0.18 |
-0.22 |
-0.31 |
| 期末基金资产净值 |
914,595,529.00 |
1,169,709,417.00 |
338,270,088.90 |
24,837,669.83 |
| 期末基金份额净值 |
1.54 |
1.58 |
1.54 |
0.91 |
| 基金份额累计净值增长率(%) |
54.09 |
58.45 |
53.64 |
-9.30 |
微信公众号
证券之星APP
基本资料
